Roughly 1 in 8 American adults take GLP-1 medications for diabetes or weight loss and the number continues growing, according ...
EPS rebound, ~18% annual returns through 2030, strong balance sheet, 2.9% yield & dividend growth. Click to read more.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果